智通财经APP获悉，心玮医疗-B(06609)涨超6%，截至发稿，涨6.21%，报59.9港元，成交额1738.38万港元。
消息面上，心玮医疗发布2025年中期业绩，该集团取得收益人民币1.86亿元(单位下同)，同比增加44.4%；毛利1.27亿元，同比增加53.9%；股东应占净利润5093.8万元，同比扭亏为盈。公告指，该等改善主要归因于公司新推出的出血性脑卒中治疗器械收益增加、缺血性脑卒中治疗器械及其他出血性脑卒中治疗器械销量上升所带动的业务增长以及公司整体费用比率下降。
此外，公司不断推动神经介入业务向差异化治疗类器械聚焦的升级。缺血性脑卒中治疗器械及其他通路器械的销量分别上涨38.3%及29.2%。出血性脑卒中治疗器械带动的收入较2024年同期增加约3770万元，主要原因是新器械的推出。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.